ArticleJournal of cancer research and clinical oncology2023

Investigation and verification of GIMAP6 as a robust biomarker for prognosis and tumor immunity in lung adenocarcinoma.

Xiuqiong Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.